JP2024532765A5 - - Google Patents
Info
- Publication number
- JP2024532765A5 JP2024532765A5 JP2024508389A JP2024508389A JP2024532765A5 JP 2024532765 A5 JP2024532765 A5 JP 2024532765A5 JP 2024508389 A JP2024508389 A JP 2024508389A JP 2024508389 A JP2024508389 A JP 2024508389A JP 2024532765 A5 JP2024532765 A5 JP 2024532765A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- use according
- hydrogen
- formula
- deuterium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163232538P | 2021-08-12 | 2021-08-12 | |
| US63/232,538 | 2021-08-12 | ||
| US202163233059P | 2021-08-13 | 2021-08-13 | |
| US63/233,059 | 2021-08-13 | ||
| PCT/US2022/040190 WO2023018954A1 (en) | 2021-08-12 | 2022-08-12 | Treatment of jak-inhibition-responsive disorders with prodrugs of jak inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024532765A JP2024532765A (ja) | 2024-09-10 |
| JP2024532765A5 true JP2024532765A5 (enExample) | 2025-08-19 |
Family
ID=83188710
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024508389A Pending JP2024532765A (ja) | 2021-08-12 | 2022-08-12 | Ｊａｋ阻害剤のプロドラッグを用いたｊａｋ阻害応答性障害の治療 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240307401A1 (enExample) |
| EP (1) | EP4384173A1 (enExample) |
| JP (1) | JP2024532765A (enExample) |
| AU (1) | AU2022328282A1 (enExample) |
| CA (1) | CA3228509A1 (enExample) |
| WO (1) | WO2023018954A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116870012A (zh) * | 2023-07-26 | 2023-10-13 | 北京大学宁波海洋药物研究院 | 一类甾体硫酸酯化合物在制备jak激酶抑制剂中的应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9925962D0 (en) | 1999-11-02 | 1999-12-29 | Novartis Ag | Organic compounds |
| PT1390063E (pt) | 2001-05-03 | 2005-03-31 | Hoffmann La Roche | Forma de dosagem farmaceutica de mesilato de nelfinavir amorfo |
| US20060094744A1 (en) | 2004-09-29 | 2006-05-04 | Maryanoff Cynthia A | Pharmaceutical dosage forms of stable amorphous rapamycin like compounds |
| DK3219705T3 (da) | 2005-12-28 | 2020-04-14 | Vertex Pharma | Farmaceutiske sammensætninger af den amorfe form af n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinolin-3-carboxamid |
| PE20211639A1 (es) | 2009-01-15 | 2021-08-24 | Incyte Holdings Corp | Procesos para preparar inhibidores de jak y compuestos intermediarios relacionado |
| DK3882249T3 (da) | 2012-06-15 | 2025-08-25 | Sun Pharmaceutical Ind Inc | Deutererede derivater af ruxolitinib |
| LT3452039T (lt) | 2016-05-04 | 2024-10-25 | Sun Pharmaceutical Industries, Inc. | Plaukų slinkimo sutrikimo gydymas deuterintais jak inhibitoriais |
| CN107759601B (zh) * | 2016-08-23 | 2020-09-11 | 苏州旺山旺水生物医药有限公司 | 一种jak抑制剂及其盐的制备方法 |
| JP2020520955A (ja) * | 2017-05-23 | 2020-07-16 | セラヴァンス バイオファーマ アール＆ディー アイピー， エルエルシー | ヤヌスキナーゼ阻害剤のグルクロニドプロドラッグ |
| CN107915738B (zh) | 2017-11-14 | 2019-07-26 | 海化生命(厦门)科技有限公司 | 用于合成巴瑞替尼的关键中间体2的制备方法 |
| CA3129096A1 (en) | 2019-02-06 | 2020-08-13 | Concert Pharmaceuticals, Inc. | Process for preparing enantiomerically enriched jak inhibitors |
| KR20230044411A (ko) | 2020-06-29 | 2023-04-04 | 콘서트 파마슈티컬즈, 인크. | Jak 억제제를 제조하기 위한 방법 및 중간체 |
-
2022
- 2022-08-12 EP EP22764557.9A patent/EP4384173A1/en active Pending
- 2022-08-12 CA CA3228509A patent/CA3228509A1/en active Pending
- 2022-08-12 AU AU2022328282A patent/AU2022328282A1/en active Pending
- 2022-08-12 WO PCT/US2022/040190 patent/WO2023018954A1/en not_active Ceased
- 2022-08-12 JP JP2024508389A patent/JP2024532765A/ja active Pending
- 2022-08-12 US US18/682,339 patent/US20240307401A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10562904B2 (en) | Synthesis process of ruxolitinib | |
| CN116987112B (zh) | 制备氨基嘧啶衍生物的改善方法 | |
| AU2018308039B2 (en) | Novel intermediates useful for the synthesis of aminopyrimidine derivatives, process for preparing the same, and process for preparing aminopyrimidine derivatives using the same | |
| JP2014532054A5 (enExample) | ||
| WO2016191303A1 (en) | Synthesis of heterocyclic compounds | |
| RU2014117635A (ru) | Способы получения соединений, которые можно использовать в качестве ингибиторов киназы atr | |
| WO2019079485A1 (en) | AMINO-SUBSTITUTED HETEROCYCLIC COMPOUNDS AS EHMT2 INHIBITORS AND DERIVATIVES THEREOF | |
| Gao et al. | 1-Hydroxypyrido [2, 3-d] pyrimidin-2 (1H)-ones as novel selective HIV integrase inhibitors obtained via privileged substructure-based compound libraries | |
| EP3030565B1 (en) | Novel substituted condensed pyrimidine compounds | |
| CN108101840A (zh) | 托吡司他及其中间体制备方法 | |
| JP2025503599A (ja) | １－アミノベンゾ［４，５］イミダゾ［１，２］ピラジン－３－ホルムアミド系化合物およびその製造と使用 | |
| Hasník et al. | Synthesis of (purin-6-yl) acetates and 6-(2-hydroxyethyl) purines via cross-couplings of 6-chloropurines with the Reformatsky reagent | |
| CN112159360B (zh) | 2-二甲胺基-6-苯甲胺基取代的三嗪类化合物的制备方法 | |
| CN115125554A (zh) | 5-胺基-1,2,4-三唑类衍生物的制备方法 | |
| CN102924454A (zh) | 恩替卡韦的合成方法 | |
| CN103408559B (zh) | 一种喜树碱及其衍生物的快速合成方法 | |
| Liu et al. | Physicochemical property-driven optimization of diarylaniline compounds as potent HIV-1 non-nucleoside reverse transcriptase inhibitors | |
| Zhao et al. | Synthesis, X‐ray crystal structure and biological activities of α‐phenoxyl‐1, 2, 3‐thiadiazoleacetamide | |
| JP2025514712A5 (enExample) | ||
| Prestat et al. | Synthesis of 3′-O2-(Azaheterocycle)-Thymidines | |
| CN113943251B (zh) | 双环庚烯基氨基取代的氮杂芳环类化合物及其医药用途 | |
| Fujii et al. | THE CYCLOADDITION OF 2-PHENYLAMINO-1-AZAAZULENE WITH DIPHENYLACETYLENE USING PALLADIUM CATALYTIC SYSTEMS | |
| CN110407840A (zh) | 一种艾维替尼的制备方法 | |
| HK40032181A (en) | Process for preparing aminopyrimidine derivatives | |
| CN108623582A (zh) | 一类新型含取代基吡啶并嘧啶化合物的制备方法 |